Cargando…

Stable high frequencies of sulfadoxine–pyrimethamine resistance associated mutations and absence of K13 mutations in Plasmodium falciparum 3 and 4 years after the introduction of artesunate plus sulfadoxine–pyrimethamine in Ujjain, Madhya Pradesh, India

BACKGROUND: Artesunate plus sulfadoxine–pyrimethamine (ASP) is first-line treatment for uncomplicated Plasmodium falciparum malaria in most of India, except for six North-eastern provinces where treatment failure rates were high. In Ujjain, central India, the frequency of mutations associated with i...

Descripción completa

Detalles Bibliográficos
Autores principales: Pathak, Ashish, Mårtensson, Andreas, Gawariker, Sudhir, Sharma, Ashish, Diwan, Vishal, Purohit, Manju, Ursing, Johan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7427725/
https://www.ncbi.nlm.nih.gov/pubmed/32795288
http://dx.doi.org/10.1186/s12936-020-03274-w
_version_ 1783570935917314048
author Pathak, Ashish
Mårtensson, Andreas
Gawariker, Sudhir
Sharma, Ashish
Diwan, Vishal
Purohit, Manju
Ursing, Johan
author_facet Pathak, Ashish
Mårtensson, Andreas
Gawariker, Sudhir
Sharma, Ashish
Diwan, Vishal
Purohit, Manju
Ursing, Johan
author_sort Pathak, Ashish
collection PubMed
description BACKGROUND: Artesunate plus sulfadoxine–pyrimethamine (ASP) is first-line treatment for uncomplicated Plasmodium falciparum malaria in most of India, except for six North-eastern provinces where treatment failure rates were high. In Ujjain, central India, the frequency of mutations associated with increased drug tolerance, but not overt resistance to sulfadoxine and pyrimethamine were 9% and > 80%, respectively, in 2009 and 2010, just prior to the introduction of ASP. The frequency of drug resistance associated mutations in Ujjain in 2015–2016 after 3–4 years of ASP use, are reported. METHODS: Blood samples from patients with P. falciparum mono-infection verified by microscopy were collected on filter-paper at all nine major pathology laboratories in Ujjain city. Codons pfdhfr 16–185, pfdhps 436–632 and K13 407–689 were identified by sequencing. Pfcrt K76T and pfmdr1 N86Y were identified by restriction fragment length polymorphism. RESULTS: Sulfadoxine–pyrimethamine resistance-associated pfdhfr 108 N and 59R alleles were found in 100/104 (96%) and 87/91 (96%) samples, respectively. Pfdhps 437G was found in 10/105 (10%) samples. Double mutant pfdhfr 59R + 108 N were found in 75/81 (93%) samples. Triple mutant pfdhfr 59R + 108 N and pfdhps 437G were found in 6/78 (8%) samples. Chloroquine-resistance-associated pfcrt 76T was found in 102/102 (100%). Pfmdr1 N86 and 86Y were identified in 83/115 (72%) and 32/115 (28%) samples, respectively. CONCLUSION: The frequency of P. falciparum with reduced susceptibility to sulfadoxine–pyrimethamine remained high, but did not appear to have increased significantly since the introduction of ASP. No polymorphisms in K13 associated with decreased artemisinin susceptibility were found. ASP probably remained effective, supporting continued ASP use.
format Online
Article
Text
id pubmed-7427725
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-74277252020-08-17 Stable high frequencies of sulfadoxine–pyrimethamine resistance associated mutations and absence of K13 mutations in Plasmodium falciparum 3 and 4 years after the introduction of artesunate plus sulfadoxine–pyrimethamine in Ujjain, Madhya Pradesh, India Pathak, Ashish Mårtensson, Andreas Gawariker, Sudhir Sharma, Ashish Diwan, Vishal Purohit, Manju Ursing, Johan Malar J Research BACKGROUND: Artesunate plus sulfadoxine–pyrimethamine (ASP) is first-line treatment for uncomplicated Plasmodium falciparum malaria in most of India, except for six North-eastern provinces where treatment failure rates were high. In Ujjain, central India, the frequency of mutations associated with increased drug tolerance, but not overt resistance to sulfadoxine and pyrimethamine were 9% and > 80%, respectively, in 2009 and 2010, just prior to the introduction of ASP. The frequency of drug resistance associated mutations in Ujjain in 2015–2016 after 3–4 years of ASP use, are reported. METHODS: Blood samples from patients with P. falciparum mono-infection verified by microscopy were collected on filter-paper at all nine major pathology laboratories in Ujjain city. Codons pfdhfr 16–185, pfdhps 436–632 and K13 407–689 were identified by sequencing. Pfcrt K76T and pfmdr1 N86Y were identified by restriction fragment length polymorphism. RESULTS: Sulfadoxine–pyrimethamine resistance-associated pfdhfr 108 N and 59R alleles were found in 100/104 (96%) and 87/91 (96%) samples, respectively. Pfdhps 437G was found in 10/105 (10%) samples. Double mutant pfdhfr 59R + 108 N were found in 75/81 (93%) samples. Triple mutant pfdhfr 59R + 108 N and pfdhps 437G were found in 6/78 (8%) samples. Chloroquine-resistance-associated pfcrt 76T was found in 102/102 (100%). Pfmdr1 N86 and 86Y were identified in 83/115 (72%) and 32/115 (28%) samples, respectively. CONCLUSION: The frequency of P. falciparum with reduced susceptibility to sulfadoxine–pyrimethamine remained high, but did not appear to have increased significantly since the introduction of ASP. No polymorphisms in K13 associated with decreased artemisinin susceptibility were found. ASP probably remained effective, supporting continued ASP use. BioMed Central 2020-08-14 /pmc/articles/PMC7427725/ /pubmed/32795288 http://dx.doi.org/10.1186/s12936-020-03274-w Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Pathak, Ashish
Mårtensson, Andreas
Gawariker, Sudhir
Sharma, Ashish
Diwan, Vishal
Purohit, Manju
Ursing, Johan
Stable high frequencies of sulfadoxine–pyrimethamine resistance associated mutations and absence of K13 mutations in Plasmodium falciparum 3 and 4 years after the introduction of artesunate plus sulfadoxine–pyrimethamine in Ujjain, Madhya Pradesh, India
title Stable high frequencies of sulfadoxine–pyrimethamine resistance associated mutations and absence of K13 mutations in Plasmodium falciparum 3 and 4 years after the introduction of artesunate plus sulfadoxine–pyrimethamine in Ujjain, Madhya Pradesh, India
title_full Stable high frequencies of sulfadoxine–pyrimethamine resistance associated mutations and absence of K13 mutations in Plasmodium falciparum 3 and 4 years after the introduction of artesunate plus sulfadoxine–pyrimethamine in Ujjain, Madhya Pradesh, India
title_fullStr Stable high frequencies of sulfadoxine–pyrimethamine resistance associated mutations and absence of K13 mutations in Plasmodium falciparum 3 and 4 years after the introduction of artesunate plus sulfadoxine–pyrimethamine in Ujjain, Madhya Pradesh, India
title_full_unstemmed Stable high frequencies of sulfadoxine–pyrimethamine resistance associated mutations and absence of K13 mutations in Plasmodium falciparum 3 and 4 years after the introduction of artesunate plus sulfadoxine–pyrimethamine in Ujjain, Madhya Pradesh, India
title_short Stable high frequencies of sulfadoxine–pyrimethamine resistance associated mutations and absence of K13 mutations in Plasmodium falciparum 3 and 4 years after the introduction of artesunate plus sulfadoxine–pyrimethamine in Ujjain, Madhya Pradesh, India
title_sort stable high frequencies of sulfadoxine–pyrimethamine resistance associated mutations and absence of k13 mutations in plasmodium falciparum 3 and 4 years after the introduction of artesunate plus sulfadoxine–pyrimethamine in ujjain, madhya pradesh, india
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7427725/
https://www.ncbi.nlm.nih.gov/pubmed/32795288
http://dx.doi.org/10.1186/s12936-020-03274-w
work_keys_str_mv AT pathakashish stablehighfrequenciesofsulfadoxinepyrimethamineresistanceassociatedmutationsandabsenceofk13mutationsinplasmodiumfalciparum3and4yearsaftertheintroductionofartesunateplussulfadoxinepyrimethamineinujjainmadhyapradeshindia
AT martenssonandreas stablehighfrequenciesofsulfadoxinepyrimethamineresistanceassociatedmutationsandabsenceofk13mutationsinplasmodiumfalciparum3and4yearsaftertheintroductionofartesunateplussulfadoxinepyrimethamineinujjainmadhyapradeshindia
AT gawarikersudhir stablehighfrequenciesofsulfadoxinepyrimethamineresistanceassociatedmutationsandabsenceofk13mutationsinplasmodiumfalciparum3and4yearsaftertheintroductionofartesunateplussulfadoxinepyrimethamineinujjainmadhyapradeshindia
AT sharmaashish stablehighfrequenciesofsulfadoxinepyrimethamineresistanceassociatedmutationsandabsenceofk13mutationsinplasmodiumfalciparum3and4yearsaftertheintroductionofartesunateplussulfadoxinepyrimethamineinujjainmadhyapradeshindia
AT diwanvishal stablehighfrequenciesofsulfadoxinepyrimethamineresistanceassociatedmutationsandabsenceofk13mutationsinplasmodiumfalciparum3and4yearsaftertheintroductionofartesunateplussulfadoxinepyrimethamineinujjainmadhyapradeshindia
AT purohitmanju stablehighfrequenciesofsulfadoxinepyrimethamineresistanceassociatedmutationsandabsenceofk13mutationsinplasmodiumfalciparum3and4yearsaftertheintroductionofartesunateplussulfadoxinepyrimethamineinujjainmadhyapradeshindia
AT ursingjohan stablehighfrequenciesofsulfadoxinepyrimethamineresistanceassociatedmutationsandabsenceofk13mutationsinplasmodiumfalciparum3and4yearsaftertheintroductionofartesunateplussulfadoxinepyrimethamineinujjainmadhyapradeshindia